Reinventing MS therapy. Cellerys was founded in 2015 as a spin-out from the University of Zurich, where it conducted a successful phase I clinical trial with the support of Wyss Zurich, a joint accelerator of the University of Zurich and ETH Zurich. The phase I trial showed excellent tolerability and safety and indicated the induction of several tolerance mechanisms.
Company Details
- Employees
- 16
- Founded
- 2015
- Address
- Wagistrasse 21, Schlieren,zurich 8952,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.cellerys.com
- HQ
- Schlieren, Zurich
Cellerys Ag Questions
Cellerys Ag's website is http://www.cellerys.com
Cellerys Ag's LinkedIn profile is https://ch.linkedin.com/company/cellerys-ag
Cellerys Ag has
16 employees.
View email and phone details for 16
employees at Cellerys Ag.
Cellerys Ag's industry is
Pharmaceutical Manufacturing
Cellerys Ag's top competitors are
Numab Therapeutics Ag,
Novartis,
Akademischer Sportverband Zürich (Asvz),
Athebio Ag,
Immunos Therapeutics Ag,
Nourand,
Coccitech S.r.l.,
European Biopharma Therapeutics,
Noubrain,
Memo Therapeutics Ag.
Cellerys Ag's categories are Pharmaceutical Manufacturing
Cellerys Ag's founding year is 2015
